New insights: A role for O-GlcNAcylation in diabetic complications

Sherket B. Peterson, Gerald Warren Hart

Research output: Contribution to journalArticle

Abstract

Diabetes is a debilitating metabolic disease that is riddled with complications that can cause blindness, renal failure, nerve damage, and cardiovascular disease. Poor glycemic control is thought to be a key initiator in the progression of diabetic complications. Hyperglycemia has been shown to increase flux through the hexosamine biosynthetic pathway (HBP) to initiate many of the toxic effects of glucose. The major endpoint of the HBP is the formation of uridine diphosphate β-D-N-acetylglucosamine (UDP-GlcNAc), the donor for protein O-GlcNAcylation, and complex extracellular glycosylation. O-GlcNAcylation is a dynamic nutrient sensitive post-translational modification that is characterized by the addition of single β-D-N-acetylglucosamine to the serine and/or threonine residues of almost every functional class of protein. O-GlcNAc is extremely abundant and cycles on and off proteins by the concerted action of a transferase and a hydrolase. O-GlcNAc serves as a nutrient/stress sensor regulating several processes, such as signaling, transcription, cytoskeletal dynamics, and cell division. Altered O-GlcNAc signaling is directly involved in the pathogenesis of diabetes and new insights are revealing the importance of O-GlcNAc in diabetic complications. The goal of this review is to summarize O-GlcNAcylation, to present the current evidence for the role of O-GlcNAc in diabetic complications, and discuss conclusions and future directions for research on O-GlcNAc in the progression of diabetic complications.

Original languageEnglish (US)
Pages (from-to)1-12
Number of pages12
JournalCritical Reviews in Biochemistry and Molecular Biology
DOIs
StateAccepted/In press - Jan 22 2016

Fingerprint

Diabetes Complications
Hexosamines
Medical problems
Nutrients
Biosynthetic Pathways
Uridine Diphosphate N-Acetylglucosamine
Glycosylation
Proteins
Uridine Diphosphate
Acetylglucosamine
Poisons
Hydrolases
Threonine
Transcription
Transferases
Food
Serine
Metabolic Diseases
Blindness
Post Translational Protein Processing

Keywords

  • Cardiovascular disease
  • diabetes
  • diabetic nephropathy
  • diabetic retinopathy
  • glucose toxicity
  • hexosamine biosynthetic pathway
  • hyperglycemia
  • O-GlcNAc

ASJC Scopus subject areas

  • Molecular Biology
  • Biochemistry

Cite this

New insights : A role for O-GlcNAcylation in diabetic complications. / Peterson, Sherket B.; Hart, Gerald Warren.

In: Critical Reviews in Biochemistry and Molecular Biology, 22.01.2016, p. 1-12.

Research output: Contribution to journalArticle

@article{3c4863f1723b4fe8aed548b0ea047115,
title = "New insights: A role for O-GlcNAcylation in diabetic complications",
abstract = "Diabetes is a debilitating metabolic disease that is riddled with complications that can cause blindness, renal failure, nerve damage, and cardiovascular disease. Poor glycemic control is thought to be a key initiator in the progression of diabetic complications. Hyperglycemia has been shown to increase flux through the hexosamine biosynthetic pathway (HBP) to initiate many of the toxic effects of glucose. The major endpoint of the HBP is the formation of uridine diphosphate β-D-N-acetylglucosamine (UDP-GlcNAc), the donor for protein O-GlcNAcylation, and complex extracellular glycosylation. O-GlcNAcylation is a dynamic nutrient sensitive post-translational modification that is characterized by the addition of single β-D-N-acetylglucosamine to the serine and/or threonine residues of almost every functional class of protein. O-GlcNAc is extremely abundant and cycles on and off proteins by the concerted action of a transferase and a hydrolase. O-GlcNAc serves as a nutrient/stress sensor regulating several processes, such as signaling, transcription, cytoskeletal dynamics, and cell division. Altered O-GlcNAc signaling is directly involved in the pathogenesis of diabetes and new insights are revealing the importance of O-GlcNAc in diabetic complications. The goal of this review is to summarize O-GlcNAcylation, to present the current evidence for the role of O-GlcNAc in diabetic complications, and discuss conclusions and future directions for research on O-GlcNAc in the progression of diabetic complications.",
keywords = "Cardiovascular disease, diabetes, diabetic nephropathy, diabetic retinopathy, glucose toxicity, hexosamine biosynthetic pathway, hyperglycemia, O-GlcNAc",
author = "Peterson, {Sherket B.} and Hart, {Gerald Warren}",
year = "2016",
month = "1",
day = "22",
doi = "10.3109/10409238.2015.1135102",
language = "English (US)",
pages = "1--12",
journal = "Critical Reviews in Biochemistry and Molecular Biology",
issn = "1040-9238",
publisher = "Informa Healthcare",

}

TY - JOUR

T1 - New insights

T2 - A role for O-GlcNAcylation in diabetic complications

AU - Peterson, Sherket B.

AU - Hart, Gerald Warren

PY - 2016/1/22

Y1 - 2016/1/22

N2 - Diabetes is a debilitating metabolic disease that is riddled with complications that can cause blindness, renal failure, nerve damage, and cardiovascular disease. Poor glycemic control is thought to be a key initiator in the progression of diabetic complications. Hyperglycemia has been shown to increase flux through the hexosamine biosynthetic pathway (HBP) to initiate many of the toxic effects of glucose. The major endpoint of the HBP is the formation of uridine diphosphate β-D-N-acetylglucosamine (UDP-GlcNAc), the donor for protein O-GlcNAcylation, and complex extracellular glycosylation. O-GlcNAcylation is a dynamic nutrient sensitive post-translational modification that is characterized by the addition of single β-D-N-acetylglucosamine to the serine and/or threonine residues of almost every functional class of protein. O-GlcNAc is extremely abundant and cycles on and off proteins by the concerted action of a transferase and a hydrolase. O-GlcNAc serves as a nutrient/stress sensor regulating several processes, such as signaling, transcription, cytoskeletal dynamics, and cell division. Altered O-GlcNAc signaling is directly involved in the pathogenesis of diabetes and new insights are revealing the importance of O-GlcNAc in diabetic complications. The goal of this review is to summarize O-GlcNAcylation, to present the current evidence for the role of O-GlcNAc in diabetic complications, and discuss conclusions and future directions for research on O-GlcNAc in the progression of diabetic complications.

AB - Diabetes is a debilitating metabolic disease that is riddled with complications that can cause blindness, renal failure, nerve damage, and cardiovascular disease. Poor glycemic control is thought to be a key initiator in the progression of diabetic complications. Hyperglycemia has been shown to increase flux through the hexosamine biosynthetic pathway (HBP) to initiate many of the toxic effects of glucose. The major endpoint of the HBP is the formation of uridine diphosphate β-D-N-acetylglucosamine (UDP-GlcNAc), the donor for protein O-GlcNAcylation, and complex extracellular glycosylation. O-GlcNAcylation is a dynamic nutrient sensitive post-translational modification that is characterized by the addition of single β-D-N-acetylglucosamine to the serine and/or threonine residues of almost every functional class of protein. O-GlcNAc is extremely abundant and cycles on and off proteins by the concerted action of a transferase and a hydrolase. O-GlcNAc serves as a nutrient/stress sensor regulating several processes, such as signaling, transcription, cytoskeletal dynamics, and cell division. Altered O-GlcNAc signaling is directly involved in the pathogenesis of diabetes and new insights are revealing the importance of O-GlcNAc in diabetic complications. The goal of this review is to summarize O-GlcNAcylation, to present the current evidence for the role of O-GlcNAc in diabetic complications, and discuss conclusions and future directions for research on O-GlcNAc in the progression of diabetic complications.

KW - Cardiovascular disease

KW - diabetes

KW - diabetic nephropathy

KW - diabetic retinopathy

KW - glucose toxicity

KW - hexosamine biosynthetic pathway

KW - hyperglycemia

KW - O-GlcNAc

UR - http://www.scopus.com/inward/record.url?scp=84958036239&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958036239&partnerID=8YFLogxK

U2 - 10.3109/10409238.2015.1135102

DO - 10.3109/10409238.2015.1135102

M3 - Article

C2 - 26806492

AN - SCOPUS:84958036239

SP - 1

EP - 12

JO - Critical Reviews in Biochemistry and Molecular Biology

JF - Critical Reviews in Biochemistry and Molecular Biology

SN - 1040-9238

ER -